Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer leaves COVID product forecast unchanged, shares fall )
Also on site :
Pfizer leaves COVID product forecast unchanged, shares fall ...Middle East
Pfizer Inc did not raise its 2022 forecast for sales of its COVID-19 vaccine and antiviral treatment on Thursday, and its shares fell nearly 5% before recovering. The U.S. drugmaker maintained its full-year forecast of around $54 billion for its COVID products, even as second-quarter sales of its Paxlovid antiviral pills were much higher-than-expected, raising concerns among some analysts over Pfizer's long-term growth prospects.
Most Viewed Opinion
جديد الاخبار